<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-P6051NRV</identifier><date>2015</date><creator>Kasahara, Norimitsu</creator><relation>documents/doc/P/URN_NBN_SI_doc-P6051NRV_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-P6051NRV_001.txt</relation><format format_type="issue">4</format><format format_type="volume">49</format><format format_type="type">article</format><format format_type="extent">str. 409-415, VII</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">285184256</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-P6051NRV</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">kemoradioterapija</subject><subject language_type_id="slv">pljuča</subject><subject language_type_id="slv">preživetje</subject><subject language_type_id="slv">rak (medicina)</subject><title>Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy</title></Record>